Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan: Veru Inc. (VERU)
The EV/EBITDA valuation trend for Veru Inc. (VERU) shows a figure of 0.00. Veru Inc. is accelerating the launch of anti-tumor agents through partnerships with clinics. A stable staff of specialized experts and regulators supports current objectives. The business relies on the development of cutting-edge cancer drugs and weight control agents that preserve muscle tissue.
verupharma.com (VERU) - rincian metrik lan laporan keuangan
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi bursa perusahaan:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Rasio Total Utang marang Ekuitas Veru Inc.|VERU - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Veru|VERU - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Veru Corporation|VERU - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Veru|Indikator likuiditas cepet verupharma.com
- data bathi bisnis lan rasio investasi:
VERU - Bathi pungkasan|Proyeksi bathi mangsa ngarep Veru Inc.|VERU - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Veru Inc.|VERU - Rasio P/E diaturake wutah|Pangali EV/EBITDA Veru Corporation|VERU - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Veru|VERU - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan verupharma.com|VERU - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Veru Inc.
Analisis wiwitan perusahaan:VERU (Veru Pharma)
This indicator compares the total enterprise value to operating profit before depreciation and interest, allowing for an assessment of the real value of assets regardless of debt load and tax regime. Monitoring the EV/EBITDA valuation multiple serves as a stress-testing tool, confirming the resilience of Veru Inc. through high margins and the diversification of oncology drug sales, which mitigates the risks of regulatory restrictions.
Pesaing wigati
Pangali EV/EBITDA ONC (BeiGene Corp)|HALO - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|RVMD: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|AAPG - Pangali EV/EBITDA|CG Oncology (CGON) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|UroGen Pharma Ltd - Nilai bisnis marang bathi operasional sadurunge panyusutan|BCAX (Bicara Bio) - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Personalis Genomics PSNL|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ERAS (Erasca, Inc.)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan DCTH (delcath.com)|Pangali EV/EBITDA YMAB (Y-mAbs Therapeutics, Inc.)|Aura Biosciences Inc (AURA) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|CADL - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan ARAY (Accuray, Inc.)|SLS (sellaslifesciences.com) - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|actuatetherapeutics.com (ACTU) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CTOR|HURA: Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA TARA|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Fate Pharma|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Aadi Bioscience WHWK|TCRX: Nilai perusahaan marang bathi operasional sadurunge panyusutan|Champions Oncology Corp - Pangali EV/EBITDA|XBiotech Inc. (XBIT) - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|CVM (cel-sci.com) - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|OSTX - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan RADX|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ARTV|Pangali EV/EBITDA ANL|TPST - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Xilio Therapeutics XLO|Nilai bisnis marang bathi operasional sadurunge panyusutan RENB|MURA: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|KAPA - Pangali EV/EBITDA|OKUR: Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CytoMed Therapeutics Limited|CRIS (Curis Inc.) - Pangali EV/EBITDA|Pangali EV/EBITDA Apollomics Corp|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tharimmune, Inc. (THAR)|advanbiomed.com - Nilai perusahaan marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA GNPX (Genprex)|CLDI - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Sunshine Biopharma - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Xenetic Biosciences|Salarius Pharmaceuticals (SLRX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|purple-biotech.com - Nilai bisnis marang bathi operasional sadurunge panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan AONC|BGNE: Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA CKPT|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Elevation Oncology Inc. ELEV|iCAD - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Pangali EV/EBITDA Ikena Oncology Inc. IKNA|NTBL - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan VIRX (Viracta Therapeutics)|MOR: Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NAYA Biosciences Corp (NAYA)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan AAPGV
